Search

Tai T. Nguyen

Examiner (ID: 7862, Phone: (571)272-2961 , Office: P/2685 )

Most Active Art Unit
2685
Art Unit(s)
2685, 2632, 2612, 2736
Total Applications
2499
Issued Applications
2068
Pending Applications
144
Abandoned Applications
321

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18337026 [patent_doc_number] => 20230128975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR [patent_app_type] => utility [patent_app_number] => 18/081163 [patent_app_country] => US [patent_app_date] => 2022-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081163 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/081163
PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR Dec 13, 2022 Pending
Array ( [id] => 18336246 [patent_doc_number] => 20230128195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => SYNTHESIS OF HALICHONDRINS [patent_app_type] => utility [patent_app_number] => 18/058441 [patent_app_country] => US [patent_app_date] => 2022-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 128021 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058441 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/058441
SYNTHESIS OF HALICHONDRINS Nov 22, 2022 Pending
Array ( [id] => 18962822 [patent_doc_number] => 11896561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Compositions including a cannabinoid and protocatechuic acid [patent_app_type] => utility [patent_app_number] => 18/056146 [patent_app_country] => US [patent_app_date] => 2022-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8275 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056146 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/056146
Compositions including a cannabinoid and protocatechuic acid Nov 15, 2022 Issued
Array ( [id] => 19692783 [patent_doc_number] => 20250011328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => INDOLE ALKALOID AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/264435 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264435 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/264435
INDOLE ALKALOID AND PREPARATION METHOD AND USE THEREOF Nov 8, 2022 Pending
Array ( [id] => 18347078 [patent_doc_number] => 20230135188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => FE/CU-MEDIATED KETONE SYNTHESIS [patent_app_type] => utility [patent_app_number] => 18/053921 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053921 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053921
FE/CU-MEDIATED KETONE SYNTHESIS Nov 8, 2022 Pending
Array ( [id] => 19256825 [patent_doc_number] => 12016854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Liquid dosage forms to treat cancer [patent_app_type] => utility [patent_app_number] => 17/975765 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 33279 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975765 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/975765
Liquid dosage forms to treat cancer Oct 27, 2022 Issued
Array ( [id] => 18326007 [patent_doc_number] => 20230124135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE [patent_app_type] => utility [patent_app_number] => 18/050888 [patent_app_country] => US [patent_app_date] => 2022-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38902 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050888 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/050888
Isoquinoline compounds and their use in treating AhR imbalance Oct 27, 2022 Issued
Array ( [id] => 18348713 [patent_doc_number] => 20230136824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => N-N-DIMETHYLTRYPTAMINE (DMT) AND DMT ANALOG COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/974443 [patent_app_country] => US [patent_app_date] => 2022-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12571 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17974443 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/974443
N-N-DIMETHYLTRYPTAMINE (DMT) AND DMT ANALOG COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF Oct 25, 2022 Pending
Array ( [id] => 18497329 [patent_doc_number] => 20230219949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN [patent_app_type] => utility [patent_app_number] => 17/969043 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32828 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969043 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/969043
INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN Oct 18, 2022 Pending
Array ( [id] => 18322235 [patent_doc_number] => 20230120363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => Process for making propene oxide [patent_app_type] => utility [patent_app_number] => 18/046150 [patent_app_country] => US [patent_app_date] => 2022-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046150 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/046150
Process for making propene oxide Oct 11, 2022 Issued
Array ( [id] => 18284102 [patent_doc_number] => 20230099574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING NOVEL DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME [patent_app_type] => utility [patent_app_number] => 17/961472 [patent_app_country] => US [patent_app_date] => 2022-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961472 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/961472
Composition for preventing or treating TNF-related diseases, containing novel derivative as active ingredient, and method for inhibiting TNF activity by using same Oct 5, 2022 Issued
Array ( [id] => 18286786 [patent_doc_number] => 20230102258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => C5AR ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/935434 [patent_app_country] => US [patent_app_date] => 2022-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/935434
C5AR ANTAGONISTS Sep 25, 2022 Abandoned
Array ( [id] => 18405761 [patent_doc_number] => 20230167112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => ERGOLINE ANALOGUES [patent_app_type] => utility [patent_app_number] => 17/932854 [patent_app_country] => US [patent_app_date] => 2022-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/932854
Ergoline analogues Sep 15, 2022 Issued
Array ( [id] => 18383354 [patent_doc_number] => 11654118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-23 [patent_title] => Compositions including a cannabinoid and protocatechuic acid [patent_app_type] => utility [patent_app_number] => 17/931735 [patent_app_country] => US [patent_app_date] => 2022-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7588 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931735 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/931735
Compositions including a cannabinoid and protocatechuic acid Sep 12, 2022 Issued
Array ( [id] => 18492241 [patent_doc_number] => 11697651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-11 [patent_title] => Ergoline analogues [patent_app_type] => utility [patent_app_number] => 17/941506 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8080 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941506 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941506
Ergoline analogues Sep 8, 2022 Issued
Array ( [id] => 18178950 [patent_doc_number] => 20230039679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => COMPOUNDS FOR INHIBITING TNIK AND MEDICAL USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/939147 [patent_app_country] => US [patent_app_date] => 2022-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17939147 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/939147
Compounds for inhibiting TNIK and medical uses thereof Sep 6, 2022 Issued
Array ( [id] => 19202707 [patent_doc_number] => 20240174606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => INDOLE COMPOUNDS, AND PREPARATION METHODS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/270743 [patent_app_country] => US [patent_app_date] => 2022-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17863 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270743 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/270743
Indole compounds, and preparation methods, and uses thereof Sep 1, 2022 Issued
Array ( [id] => 18700023 [patent_doc_number] => 11786509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Compounds for treating TNBC [patent_app_type] => utility [patent_app_number] => 17/885696 [patent_app_country] => US [patent_app_date] => 2022-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7957 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885696 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/885696
Compounds for treating TNBC Aug 10, 2022 Issued
Array ( [id] => 18295713 [patent_doc_number] => 20230105399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => 3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS [patent_app_type] => utility [patent_app_number] => 17/879320 [patent_app_country] => US [patent_app_date] => 2022-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37441 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 561 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879320 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/879320
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders Aug 1, 2022 Issued
Array ( [id] => 19860654 [patent_doc_number] => 20250099440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => A PHARMACEUTICAL COMBINATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/294510 [patent_app_country] => US [patent_app_date] => 2022-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294510 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/294510
A PHARMACEUTICAL COMBINATION AND USE THEREOF Aug 1, 2022 Pending
Menu